Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients

BACKGROUND: By depleting circulating B lymphocytes, rituximab time-dependently suppresses coronavirus disease 2019 (COVID-19) vaccines’ humoral immunogenicity for a prolonged period. The optimal time to vaccinate rituximab-exposed immune-mediated dermatologic disease (IMDD) patients is currently unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Seree-aphinan, Chutima, Ratanapokasatit, Yanisa, Suchonwanit, Poonkiat, Rattanakaemakorn, Ploysyne, O-Charoen, Pichaya, Pisitkun, Prapaporn, Suangtamai, Thanitta, Setthaudom, Chavachol, Chirasuthat, Sonphet, Chanprapaph, Kumutnart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050596/
https://www.ncbi.nlm.nih.gov/pubmed/37006291
http://dx.doi.org/10.3389/fimmu.2023.1138765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050596/
https://www.ncbi.nlm.nih.gov/pubmed/37006291
http://dx.doi.org/10.3389/fimmu.2023.1138765

Ejemplares similares